Abbott

$81.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.44 (+3.08%) As of 3:37 PM EDT today
+$2.44 (+3.08%) Today

Why Robinhood?

You can buy or sell Abbott and other stocks, options, ETFs, and crypto commission-free!

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. Read More The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Employees
107,000
Headquarters
Abbott Park, Illinois
Founded
1888
Market Cap
144.85B
Price-Earnings Ratio
38.60
Dividend Yield
1.81
Average Volume
17.02M
High Today
$82.49
Low Today
$79.61
Open Price
$81.08
Volume
8.81M
52 Week High
$92.45
52 Week Low
$61.61

Collections

ABT News

BenzingaApr 2

Detroit To Be The First City To Roll Out Abbott's 5-Minute Coronavirus Tests

Detroit will make available Abbott Laboratories (NYSE: ABT) five-minute COVID-19 tests to first responders beginning Friday. What Happened The city of Detroit
777
CNBCMar 30

Abbott Labs CEO on new coronavirus test launches: 'There's a need for more'

Abbott Laboratories has received federal clearance for two coronavirus tests in as many weeks and the company is on a mission to develop even more diagnostic de
2,424

ABT Earnings

$0.00
$0.32
$0.63
$0.95
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
per share
Actual
Available Apr 16, Pre-Market

People Also Bought

You May Also Like

Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.